This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dorros, G. Articles by He, T. Search for Related Content PubMed PubMed Citation Articles by Dorros, G. Articles by He, T. Related Collections Peripheral vascular disease Other Treatment

(Circulation. 2001;104:2057.)
© 2001 American Heart Association, Inc.

Clinical Investigation and Reports

Tibioperoneal (Outflow Lesion) Angioplasty Can Be Used as Primary Treatment in 235 Patients With Critical Limb Ischemia

Five-Year Follow-Up

Gerald Dorros, MD; Michael R. Jaff, DO; Ari M. Dorros, MD; Lynne M. Mathiak, RN; Thomas He, PhD

From the William Dorros-Isadore Feuer Interventional Cardiovascular Disease Foundation Ltd, Grafton, Wis, Wilson, Wyo, and Phoenix, Ariz (G.D., A.M.D., L.M.M.); the Heart and Vascular Institute, Morristown, NJ (M.R.J.); and St Luke’s Medical Center, Milwaukee, Wis (T.H.).

Reprint requests to Gerald Dorros, MD, FACC, Dorros-Feuer Foundation, 1331 N 7th St, Suite 215, Phoenix, AZ 85006. E-mail gdorros{at}dorrosfoundation.org

Background— In a prospective, nonrandomized, consecutive series of tibioperoneal vessel angioplasty (TPVA), critical limb ischemia (CLI) patients’ data were analyzed with regard to immediate and follow-up success.

Methods and Results— TPVA was successful in 270 of 284 critically ischemic limbs (95%), with 167 limbs (59%) requiring dilatation of 333 ipsilateral inflow obstructions to access and successfully dilate 486 of 529 (92%) tibioperoneal lesions. A clinical success (relief of rest pain or improvement of lower-extremity blood flow) was attained in 270 limbs at risk (95%). Clinical 5-year follow-up of 215 of 221 successful CLI patients (97%) with 266 successfully revascularized limbs revealed that bypass surgery occurred in 8% and significant amputations in 9% of limbs; 91% of the limbs were salvaged. The cohort’s probability of survival was 56%: 58% for Fontaine class III and 33% for class IV patients. Class III compared with class IV patients had significantly (P<0.05) fewer surgical bypasses (3% versus 16%) and amputations: above-knee, 1% versus 4%; below-knee, 3% versus 12%; and transmetatarsal, <1% versus 21%.

Conclusions— TPVA, often in combination with inflow lesions, is an effective primary treatment for critical limb ischemia. The poor cumulative survival reflects the existence of severe comorbidities, which could potentially be affected by aggressive and effective cardiovascular diagnostic and therapeutic strategies.

Key Words: angioplasty • peripheral vascular disease • surgery • vasculature

This article has been cited by other articles:

				S. A Arain and C. J White Endovascular therapy for critical limb ischemia Vascular Medicine, August 1, 2008; 13(3): 267 - 279. [Abstract] [PDF]

				D. P. Slovut and T. M Sullivan Critical limb ischemia: medical and surgical management Vascular Medicine, August 1, 2008; 13(3): 281 - 291. [Abstract] [PDF]

				A. J. Feiring Footnotes on Critical Limb Ischemia J. Am. Coll. Cardiol., May 20, 2008; 51(20): 1975 - 1976. [Full Text] [PDF]

				E. Ascher, A. P. Hingorani, and N. Marks Duplex-Guided Balloon Angioplasty of Lower Extremity Arteries Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2007; 19(1): 23 - 31. [Abstract] [PDF]

				J. Emmerich Current State and Perspective on Medical Treatment of Critical Leg Ischemia: Gene and Cell Therapy International Journal of Lower Extremity Wounds, December 1, 2005; 4(4): 234 - 241. [Abstract] [PDF]

				P. Huang, S. Li, M. Han, Z. Xiao, R. Yang, and Z. C. Han Autologous Transplantation of Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells Improves Critical Limb Ischemia in Diabetes Diabetes Care, September 1, 2005; 28(9): 2155 - 2160. [Abstract] [Full Text] [PDF]

				D Tsetis and A-M Belli The role of infrapopliteal angioplasty Br. J. Radiol., December 1, 2004; 77(924): 1007 - 1015. [Abstract] [Full Text] [PDF]

				M. A. Bettmann, M. D. Dake, L. N. Hopkins, B. T. Katzen, C. J. White, A. C. Eisenhauer, W. H. Pearce, K. A. Rosenfield, R. W. Smalling, T. A. Sos, et al. Atherosclerotic Vascular Disease Conference: Writing Group VI: Revascularization Circulation, June 1, 2004; 109(21): 2643 - 2650. [Full Text] [PDF]

				S. W. Stavropoulos, J. A. Solomon, M. C. Soulen, T. W. I. Clark, and R. D. Shlansky-Goldberg Use of Abciximab during Infrainguinal Peripheral Vascular Interventions: Initial Experience Radiology, June 1, 2003; 227(3): 657 - 661. [Abstract] [Full Text] [PDF]

				G. Tefera, W. Turnipseed, and T. Tanke Limb Salvage Angioplasty in Poor Surgical Candidates Vascular and Endovascular Surgery, March 1, 2003; 37(2): 99 - 104. [Abstract] [PDF]